Denileukin diftitox Completed Phase 2 Trials for Chronic Lymphocytic Leukemia (CLL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00055146Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)